Rna Interference Suppression Of Neurodegenerative Diseases And Methods Of Use Thereof

Abstract

The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence that encodes poly-glutamine repeat diseases, and methods of using these RNAi molecules.


Claims

Sign in to the Lens

Feedback